{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:40:14Z","timestamp":1792104014193,"version":"4.4.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jhep.2018.10.033","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T01:07:23Z","timestamp":1541725643000},"page":"531-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1951,"title":["Non-alcoholic fatty liver disease \u2013 A global public health perspective"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9313-577X","authenticated-orcid":false,"given":"Zobair M.","family":"Younossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jhep.2018.10.033_b0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/liv.13682","article-title":"Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening","volume":"38","author":"Marcellin","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.10.033_b0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jhep.2018.10.033_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2016.07.020","article-title":"Direct and indirect economic burden of chronic liver disease in the United States","volume":"15","author":"Stepanova","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0020","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.07.008","article-title":"Changing trends in etiology-based annual mortality from chronic liver disease, from 2007 through 2016","author":"Kim","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.033_b0025","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0030","first-page":"363","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.10.033_b0035","unstructured":"Tenfold increase in childhood and adolescent obesity in four decades: new study by Imperial College London and WHO 11 October 2017 News Release LONDON- http:\/\/www.who.int\/news-room\/detail\/11-10-2017-tenfold-increase-in-childhood-and-adolescent-obesity-in-four-decades-new-study-by-imperial-college-london-and-who."},{"key":"10.1016\/j.jhep.2018.10.033_b0040","unstructured":"World Obesity Facts. Obtained from the world wide web at: https:\/\/renewbariatrics.com\/obesity-rank-by-countries\/."},{"key":"10.1016\/j.jhep.2018.10.033_b0045","unstructured":"Type 2 Diabetes Mellitus-International Diabetes Federation. IDF diabetes atlas. 8th ed. 2017 obtained from the world wide web at http:\/\/www.diabetesatlas.org\/."},{"key":"10.1016\/j.jhep.2018.10.033_b0050","unstructured":"WHO Diabetes Fact Sheets. Obtained from the world wide web at: http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes."},{"key":"10.1016\/j.jhep.2018.10.033_b0055","unstructured":"Centers for Disease Control. Rates of new diagnosed cases of type 1 and type 2 diabetes on the rise among children, teens. Obtained from the world wide web at: https:\/\/www.cdc.gov\/media\/releases\/2017\/p0412-diabtes-rates.html."},{"key":"10.1016\/j.jhep.2018.10.033_b0060","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0065","unstructured":"World Health Organization (WHO). Obesity and overweight. Obtained from the world wide web at: http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"10.1016\/j.jhep.2018.10.033_b0070","unstructured":"World Health Assembly. Action plan to reduce global obesity. Obtained from the world wide web at: http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"10.1016\/j.jhep.2018.10.033_b0075","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.10.033_b0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/oby.2010.248","article-title":"The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences","volume":"19","author":"Camhi","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.jhep.2018.10.033_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139559","article-title":"The sex and race specific relationship between anthropometry and body fat composition determined from computed tomography: evidence from the multi-ethnic study of atherosclerosis","volume":"10","author":"Mongraw-Chaffin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.10.033_b0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the united states and the rest of the world","volume":"20","author":"Sayiner","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2018.10.033_b0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1590\/S0004-28032016000200013","article-title":"Nonalcoholic Fatty Liver Disease Brazilian Society of Hepatology consensus","volume":"53","author":"Cotrim","year":"2016","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.033_b0110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1665-2681(19)30879-8","article-title":"The prevalence of nonalcoholic fatty liver disease in the Americas","volume":"13","author":"L\u00f3pez-Vel\u00e1zquez","year":"2014","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1590\/1806-9282.62.03.218","article-title":"Non-alcoholic fatty liver disease (NAFLD) in different populations: a clinical and epidemiological study \u2013 sample of S\u00e3o Jos\u00e9 do Rio Preto","volume":"62","author":"Andrade","year":"2016","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"10.1016\/j.jhep.2018.10.033_b0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jgh.12036","article-title":"Epidemiology of alcoholic and nonalcoholic fatty liver disease in China","volume":"28","author":"Fan","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0125","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00535-012-0533-z","article-title":"Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study","volume":"47","author":"Eguchi","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.033_b0130","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.3748\/wjg.v16.i31.3944","article-title":"Steatosis and steatohepatitis in postmortem material from Northwestern Greece","volume":"16","author":"Zois","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.033_b0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MEG.0b013e32832fcdf0","article-title":"Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain","volume":"22","author":"Caballer\u00eda","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0140","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.23567","article-title":"Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease","volume":"51","author":"Das","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0145","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1440-1746.2009.05831.x","article-title":"Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population","volume":"24","author":"Dassanayake","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0150","series-title":"The economic cost and health burden of liver diseases in Australia","year":"2012"},{"key":"10.1016\/j.jhep.2018.10.033_b0155","unstructured":"National Health Survey: First Results, 2014\u201315. http:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/mf\/4364.0.55.001."},{"key":"10.1016\/j.jhep.2018.10.033_b0160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/osp4.13","article-title":"Obesity and the extent of liver damage among adult New Zealanders: findings from a national survey","volume":"1","author":"Coppell","year":"2015","journal-title":"Obes Sci Pract"},{"key":"10.1016\/j.jhep.2018.10.033_b0165","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1159\/000235677","article-title":"Non-alcoholic fatty liver disease in older people","volume":"55","author":"Frith","year":"2009","journal-title":"Gerontology"},{"key":"10.1016\/j.jhep.2018.10.033_b0170","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0175","first-page":"377","article-title":"Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China","volume":"8","author":"Li","year":"2009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jhep.2018.10.033_b0180","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.12688\/f1000research.12417.1","article-title":"Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: a population-based cross-sectional study","volume":"6","author":"Summart","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.jhep.2018.10.033_b0185","article-title":"Ethnic and gender differences in the prevalence of nonalcoholic steatohepatitis among bariatric surgery patients","volume":"11","author":"Messiah","year":"2016","journal-title":"Bariatr Surg Pract Patient Care"},{"key":"10.1016\/j.jhep.2018.10.033_b0190","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cld.2015.10.005","article-title":"The prevalence and pathobiology of nonalcoholic fatty liver disease in patients of different races or ethnicities","volume":"20","author":"Kalia","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2018.10.033_b0200","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/07315724.2012.10720445","article-title":"High rates of fructose malabsorption are associated with reduced liver fat in obese African Americans","volume":"31","author":"Walker","year":"2012","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jhep.2018.10.033_b0205","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00125-009-1285-z","article-title":"A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans","volume":"52","author":"Kotronen","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2018.10.033_b0210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jceh.2015.02.002","article-title":"The riddle of nonalcoholic fatty liver disease: progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis","volume":"5","author":"Sharma","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0215","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.2174\/13816128113199990381","article-title":"Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jhep.2018.10.033_b0220","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"Younossi","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhep.2018.10.033_b0230","first-page":"216","article-title":"Non-alcoholic fatty liver disease in lean subjects: characteristics and implications","volume":"5","author":"Kumar","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0235","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.metabol.2012.08.005","article-title":"In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not","volume":"62","author":"Younossi","year":"2013","journal-title":"Metabolism."},{"issue":"Supplement","key":"10.1016\/j.jhep.2018.10.033_b0240","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/S0168-8278(17)30570-6","article-title":"Liver-related mortality and morbidity of lean NAFLD is higher compared to overweight and obese NAFLD patients","volume":"66","author":"Feldman","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0245","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s10620-012-2446-3","article-title":"Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease","volume":"58","author":"Otgonsuren","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2018.10.033_b0250","doi-asserted-by":"crossref","first-page":"S909","DOI":"10.1016\/S0016-5085(14)63307-2","article-title":"379 characteristics and longterm prognosis of lean patients with nonalcoholic fatty liver disease","volume":"146","author":"Dela Cruz","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.033_b0255","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/ajg.2015.235","article-title":"Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy","volume":"110","author":"Wei","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.033_b0260","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-230X-12-123","article-title":"Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units","volume":"12","author":"Hu","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.033_b0265","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/apt.14506","article-title":"Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative","volume":"47","author":"Chan","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.10.033_b0270","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease","volume":"65","author":"Fazel","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2018.10.033_b0275","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0285","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","article-title":"A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver","volume":"59","author":"Pais","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0290","article-title":"Rates of and factors associated with placebo response in trials of pharmacotherapies for nonalcoholic steatohepatitis: systematic review and meta-analysis","author":"Han","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0295","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0300","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.jhep.2018.10.033_b0310","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010214","article-title":"Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)","volume":"97","author":"Golabi","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhep.2018.10.033_b0315","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0325","first-page":"662","article-title":"Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries","volume":"15","author":"Seyda Seydel","year":"2016","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0330","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0335","doi-asserted-by":"crossref","DOI":"10.1111\/apt.14937","article-title":"Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases","author":"Stine","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.10.033_b0340","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2017.03.011","article-title":"Global trends and predictions in hepatocellular carcinoma mortality","volume":"67","author":"Bertuccio","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0345","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s10620-013-2743-5","article-title":"Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"58","author":"Stepanova","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2018.10.033_b0350","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstr\u00f6m","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0355","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0360","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.033_b0365","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hep4.1054","article-title":"Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease","volume":"1","author":"Younossi","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2018.10.033_b0370","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.numecd.2016.06.011","article-title":"The association of lean and fat mass with all-cause mortality in older adults: The Cardiovascular Health Study","volume":"26","author":"Spahillari","year":"2016","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jhep.2018.10.033_b0375","first-page":"646","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population","volume":"10","author":"Stepanova","year":"2012","journal-title":"CGH"},{"key":"10.1016\/j.jhep.2018.10.033_b0380","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11892-015-0607-4","volume":"15","author":"Saponaro","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jhep.2018.10.033_b0385","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.jhep.2018.10.033_b0390","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.hfc.2012.06.010","article-title":"Hepatic and cardiac steatosis: are they coupled?","volume":"8","author":"Bugianesi","year":"2012","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jhep.2018.10.033_b0395","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0400","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.033_b0405","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0410","article-title":"Changing trends in etiology- and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States","author":"Kim","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0415","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/lt.25003","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation","volume":"24","author":"Younossi","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.10.033_b0420","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s10620-017-4684-x","article-title":"Liver transplantation for nonalcoholic steatohepatitis in the us: temporal trends and outcomes","volume":"62","author":"Cholankeril","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2018.10.033_b0425","article-title":"Non-alcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","author":"Younossi","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0430","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1007\/s10620-017-4595-x","article-title":"Cirrhosis patients with nonalcoholic steatohepatitis are significantly less likely to receive surveillance for hepatocellular carcinoma","volume":"62","author":"Tavakoli","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2018.10.033_b0435","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/lt.24507","article-title":"Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma","volume":"22","author":"Young","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.10.033_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0445","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1002\/cncr.28843","article-title":"Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30\u202fyears","volume":"120","author":"Kim","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2018.10.033_b0450","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.amjmed.2018.01.047","article-title":"Geographic variability in liver disease-related mortality rates in the United States","volume":"131","author":"Desai","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2018.10.033_b0455","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0460","first-page":"85","article-title":"The etiology, diagnosis and prevention of liver cirrhosis: Part 1 of a series on liver cirrhosis","volume":"110","author":"Wiegand","year":"2013","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jhep.2018.10.033_b0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187033","article-title":"Etiology and mode of presentation of chronic liver diseases in India: a multi centric study. Ray R, ed.","volume":"12","author":"Mukherjee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.10.033_b0470","article-title":"The changing epidemiology of liver diseases in the Asia-Pacific region","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2017.08.001","article-title":"Clinical and economic burden of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"22","author":"Younossi","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2018.10.033_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2016.07.020","article-title":"Direct and indirect economic burden of chronic liver disease in the United States","volume":"15","author":"Stepanova","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0485","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30094","article-title":"Healthcare cost and utilization in nonalcoholic fatty liver disease: real-world data from a large US claims database","author":"Allen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0490","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MCG.0000000000000071","article-title":"Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease","volume":"49","author":"Younossi","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.033_b0495","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MCG.0000000000000567","article-title":"Variables associated with inpatient and outpatient resource utilization among Medicare beneficiaries with nonalcoholic fatty liver disease with or without cirrhosis","volume":"51","author":"Sayiner","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.033_b0500","first-page":"288","article-title":"Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions","volume":"31","author":"Ofosu","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.033_b0505","article-title":"Burden of illness and economic model for patients with non-alcoholic steatohepatitis (NASH) in the United States","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0510","unstructured":"Patient Reported Outcomes obtained from the world wide web at: https:\/\/www.qualityforum.org\/Projects\/n-r\/Patient-Reported_Outcomes\/Patient-Reported_Outcomes.aspx, CDC 2017. Last accessed on July 16, 2018"},{"key":"10.1016\/j.jhep.2018.10.033_b0515","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1023\/A:1012588218728","article-title":"Interpreting SF-36 summary health measures: a response","volume":"10","author":"Ware","year":"2001","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jhep.2018.10.033_b0520","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.45.2.295","article-title":"Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease","volume":"45","author":"Younossi","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2018.10.033_b0525","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/liv.13391","article-title":"A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD","volume":"37","author":"Younossi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.10.033_b0530","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2015-000069","article-title":"Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)","volume":"3","author":"Chawla","year":"2016","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.033_b0535","unstructured":"National Institute of Mental Health. Depression. Obtained from the world wide web at: https:\/\/www.nimh.nih.gov\/health\/topics\/depression\/index.shtml."},{"key":"10.1016\/j.jhep.2018.10.033_b0540","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.psym.2010.12.019","article-title":"Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C","volume":"52","author":"Weinstein","year":"2011","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jhep.2018.10.033_b0545","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12955-016-0420-z","article-title":"Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL)","volume":"9","author":"Golabi","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jhep.2018.10.033_b0550","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2036.2007.03426.x","article-title":"Health-related quality of life in patients with non-alcoholic fatty liver disease","volume":"26","author":"Dan","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.10.033_b0555","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep.28416","article-title":"Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: a prospective cohort study","volume":"63","author":"Tapper","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0560","doi-asserted-by":"crossref","DOI":"10.1111\/liv.13706","article-title":"Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib","author":"Younossi","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.10.033_b0565","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/ijms17030355","article-title":"Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis C virus infection\u2014liver: the \u201cmusketeer\u201d in the spotlight","volume":"17","author":"Ballestri","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2018.10.033_b0570","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.28917","article-title":"Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: a cohort study","volume":"65","author":"Joo","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0575","article-title":"Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.10.033_b0580","unstructured":"Younossi Z, Stepanova Z, Ong J, Yilmaz Y, Duseja A, Eguchi Y, et al. Non-alcoholic Fatty Liver Disease (NAFLD) and Alcoholic Fatty Liver Disease (AFLD): The Impact of Alcohol Consumption and Metabolic Syndrome on Mortality. American Association for the Study of Liver Annual Meeting 2018, San Francisco, CA."},{"key":"10.1016\/j.jhep.2018.10.033_b0585","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2018.08.013","article-title":"The conundrum of cryptogenic cirrhosis: adverse outcomes without treatment options","volume":"69","author":"Younossi","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0590","first-page":"288","article-title":"Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions","volume":"31","author":"Ofosu","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.033_b0595","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/hep.29724","article-title":"Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0600","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cld.2017.06.010","article-title":"Treatment strategies for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"21","author":"Golabi","year":"2017","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2018.10.033_b0605","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30125","article-title":"Patient-reported outcomes and the economic effects of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis \u2013 the value proposition","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.033_b0610","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.033_b0615","unstructured":"Kamal R, Cox C, Blumenkranz E, The Kaiser Family Foundation. What do we know about social determinants of health in the U.S. and comparable countries? Chart Collections Health & Wellbeing. Posted: November 21, 2017. Accessed on 10\/23\/2018 at https:\/\/www.healthsystemtracker.org\/chart-collection\/know-social-determinants-health-u-s-comparable-countries\/#item-u-s-highest-environmental-burden-disease-compared-high-income-countries."}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818325170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818325170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T23:08:54Z","timestamp":1605395334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827818325170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":123,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0168827818325170"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2018.10.033","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic fatty liver disease \u2013 A global public health perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2018.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}